ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.67766
-0.07%
Brent Oil
82.085
0.13%
Bitcoin
68,482.93
-0.04%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Universe Pharmaceuticals Inc (UPC)

  7. Universe Pharmaceuticals Inc (UPC) Noticias

UPC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:UPC
FechaHoraFuenteTítuloSímboloCompañía
14/05/202415:06Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:UPCUniverse Pharmaceuticals Inc
07/02/202407:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
30/01/202415:30PR Newswire (US)Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial ResultsNASDAQ:UPCUniverse Pharmaceuticals Inc
30/01/202411:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:UPCUniverse Pharmaceuticals Inc
04/08/202307:30GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held SharesNASDAQ:UPCUniverse Pharmaceuticals Inc
27/07/202309:15GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
24/05/202315:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:UPCUniverse Pharmaceuticals Inc
07/03/202307:00GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:UPCUniverse Pharmaceuticals Inc
14/02/202313:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:UPCUniverse Pharmaceuticals Inc
10/02/202315:58Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:UPCUniverse Pharmaceuticals Inc
21/12/202207:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19NASDAQ:UPCUniverse Pharmaceuticals Inc
14/11/202207:00GlobeNewswire Inc.Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:UPCUniverse Pharmaceuticals Inc
27/10/202215:11Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:UPCUniverse Pharmaceuticals Inc
16/08/202207:00PR Newswire (US)Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022NASDAQ:UPCUniverse Pharmaceuticals Inc
30/03/202207:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce PlatformsNASDAQ:UPCUniverse Pharmaceuticals Inc
22/03/202207:00GlobeNewswire Inc.Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research CenterNASDAQ:UPCUniverse Pharmaceuticals Inc
11/02/202207:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:UPCUniverse Pharmaceuticals Inc
31/01/202207:00GlobeNewswire Inc.Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial ResultsNASDAQ:UPCUniverse Pharmaceuticals Inc
04/01/202207:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
29/12/202107:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
15/12/202115:30GlobeNewswire Inc.Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating OfficerNASDAQ:UPCUniverse Pharmaceuticals Inc
13/12/202107:30GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
02/08/202107:00GlobeNewswire Inc.Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2021NASDAQ:UPCUniverse Pharmaceuticals Inc
30/07/202107:00GlobeNewswire Inc.Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021NASDAQ:UPCUniverse Pharmaceuticals Inc
26/07/202107:00GlobeNewswire Inc.Universe Pharmaceuticals INC Hosts Reception for Member of Chinese Academy of Engineering and Expert Group from Tianjin University of Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
25/05/202107:00GlobeNewswire Inc.Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.NASDAQ:UPCUniverse Pharmaceuticals Inc
12/05/202107:00GlobeNewswire Inc.Universe Pharmaceuticals INC Attends West Lake Forum and Exhibits Upgraded ProductsNASDAQ:UPCUniverse Pharmaceuticals Inc
31/03/202115:30GlobeNewswire Inc.Univest Securities, LLC Announces the Full Exercise of Underwriter’s Over-Allotment Option for its Client Universe Pharmace...NASDAQ:UPCUniverse Pharmaceuticals Inc
31/03/202115:15GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Full Exercise of Underwriter’s Over-Allotment Option in the Public OfferingNASDAQ:UPCUniverse Pharmaceuticals Inc
25/03/202115:30GlobeNewswire Inc.Univest Securities, LLC Announces Closing of IPO for its Client Universe Pharmaceuticals INC (Nasdaq: UPC)NASDAQ:UPCUniverse Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:UPC

Su Consulta Reciente

NASDAQ
FCLSGX
FTP Emerging Markets Str...
AQSE
ETH-S.ST.GB
XBT Provider AB
LSE
XH23
Citi Fun 24
EU
2797T
2797T
NASDAQ
OCAXW
OCA Acquisition
NASDAQ
FTFHX
Franklin Growth Allocati...
NYSE
GETY
Getty Images
LSE
0A6R
Aethlon Medical
BITMOT
2681031
Republautric Fx 3.45% Oc...
AMEX
GTE
Gran Tierra Energy
LSE
LIN3
3x Long Linde
COIN
TESLAGBP
NYSE
PFN
PIMCO Income Strategy Fu...
HITB
LOOMBTC
Loom Network
NASDAQ
WETG
WeTrade
ASX
CBAISU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados